Foong Shu C, Fleetham Judy A, O'Keane Joseph A, Scott Selma G, Tough Suzanne C, Greene Calvin A
Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.
J Assist Reprod Genet. 2006 Mar;23(3):137-40. doi: 10.1007/s10815-005-9008-y. Epub 2006 Apr 19.
To compare outcomes in patients with unexplained infertility undergoing conventional in vitro fertilization (IVF) versus intracytoplasmic sperm injection (ICSI).
Sixty women with unexplained infertility in a Canadian tertiary-level clinic were randomized to IVF or ICSI. Subjects underwent downregulation with gonadotropin-releasing hormone agonist prior to initiation of recombinant human follicle-stimulating hormone. The primary outcome measure was fertilization rate. Secondary outcomes included implantation rate, embryo quality, clinical pregnancy rate, and live birth rate.
There was no statistically significant difference in fertilization rate (77.2% IVF vs. 82.4% ICSI), implantation rate (38.2% IVF vs. 44.4% ICSI), clinical pregnancy rate (50% in each group), or live birth rate (46.7% IVF vs. 50% ICSI). There were two cases of failed fertilization in the IVF group. There was no significant difference in embryo quality between groups.
There were no differences in clinical outcomes associated with IVF versus ICSI in the treatment of unexplained infertility.
比较接受常规体外受精(IVF)与卵胞浆内单精子注射(ICSI)的不明原因不孕症患者的治疗结果。
加拿大一家三级诊所的60名不明原因不孕症女性被随机分为IVF组或ICSI组。在开始使用重组人促卵泡激素之前,受试者先用促性腺激素释放激素激动剂进行降调节。主要结局指标为受精率。次要结局包括着床率、胚胎质量、临床妊娠率和活产率。
受精率(IVF组为77.2%,ICSI组为82.4%)、着床率(IVF组为38.2%,ICSI组为44.4%)、临床妊娠率(每组均为50%)或活产率(IVF组为46.7%,ICSI组为50%)在统计学上无显著差异。IVF组有2例受精失败。两组间胚胎质量无显著差异。
在不明原因不孕症的治疗中,IVF与ICSI的临床结局无差异。